A patient presents with hyperkalemia, metabolic acidosis, and signs of fluid overload, including bilateral crackles and peripheral edema. Given these findings, which nursing intervention is the priority to address the patient's condition?

D) Prepare the patient for hemodialysis to manage electrolyte imbalances and fluid overload

A) Administer sodium polystyrene sulfonate (Kayexalate) to reduce serum potassium levels

B) Increase the dosage of Lisinopril to better control blood pressure

C) Elevate the patient's legs to reduce peripheral edema

D) Prepare the patient for hemodialysis to manage electrolyte imbalances and fluid overload

A patient with a serum potassium level of 6.2 mEq/L, BUN of 80 mg/dL, creatinine of 7.5 mg/dL, and metabolic acidosis with partial respiratory compensation is being considered for hemodialysis. The patient is also experiencing bilateral crackles, shortness of breath, and peripheral edema. Which nursing intervention is the highest priority?

B) Prepare the patient for immediate hemodialysis to address electrolyte imbalances and fluid overload.

A) Administer sodium polystyrene sulfonate (Kayexalate) to reduce serum potassium levels.

B) Prepare the patient for immediate hemodialysis to address electrolyte imbalances and fluid overload.

C) Administer a dose of intravenous furosemide (Lasix) to reduce fluid overload and manage edema.

D) Initiate a low-potassium diet and fluid restriction to prevent further complications.

A patient with severe hyperkalemia and fluid overload is scheduled for hemodialysis. The healthcare team has administered calcium gluconate, insulin with glucose, and plans to use sodium polystyrene sulfonate. Which of the following nursing interventions is most critical in monitoring the patient's response to these treatments?

C) Assessing cardiac rhythm continuously

A) Monitoring serum calcium levels

B) Observing for signs of hypoglycemia

C) Assessing cardiac rhythm continuously

D) Measuring urine output every hour

A patient with severe hyperkalemia and pulmonary congestion is being prepared for hemodialysis. The healthcare team has administered calcium gluconate, insulin with glucose, and is considering sodium polystyrene sulfonate. Which additional action should the nurse anticipate to address the patient's fluid overload while considering his declining renal function?

C) Initiate a continuous low-dose infusion of Furosemide.

A) Increase the patient's Lisinopril dosage to manage fluid overload.

B) Administer intravenous fluid challenges to promote renal perfusion.

C) Initiate a continuous low-dose infusion of Furosemide.

D) Restrict the patient's oral fluid intake to 500 mL per day.

A patient with chronic kidney disease is experiencing fluid overload and hyperkalemia despite recent interventions. What is the most appropriate nursing action to prioritize before the patient undergoes hemodialysis?

C) Notify the healthcare provider to discuss the immediate initiation of a higher-frequency hemodialysis regimen.

A) Administer supplemental oxygen to maintain oxygen saturation above 95%.

B) Increase the dose of furosemide to enhance diuresis and reduce pulmonary congestion.

C) Notify the healthcare provider to discuss the immediate initiation of a higher-frequency hemodialysis regimen.

D) Reassess the patient's medication regimen to discontinue all potassium-sparing medications.

A patient with chronic kidney disease presents with hyperkalemia and pulmonary congestion. After initial interventions, including calcium gluconate and insulin with glucose, the patient's potassium level decreased, but pulmonary congestion persists. Which nursing intervention is most appropriate to prioritize at this time?

B) Prepare the patient for an urgent hemodialysis session.

A) Increase the rate of intravenous fluids to improve renal perfusion.

B) Prepare the patient for an urgent hemodialysis session.

C) Administer an additional dose of furosemide to enhance diuresis.

D) Initiate a low-potassium diet immediately to prevent hyperkalemia recurrence.

A patient undergoing hemodialysis experiences hypotension and dizziness during the session, and new lab results reveal metabolic acidosis with a low serum bicarbonate level. What is the most appropriate nursing intervention to address the patient's metabolic acidosis in-between dialysis sessions?

B) Administer sodium bicarbonate as prescribed

A) Encourage increased fluid intake

B) Administer sodium bicarbonate as prescribed

C) Increase protein intake to improve nutritional status

D) Monitor for signs of hyperkalemia

A patient undergoing hemodialysis begins to experience hypotensive symptoms and a decline in serum bicarbonate levels. Despite corrective measures during dialysis, these issues persist. Which nursing action should be prioritized to address the underlying cause of this patient's metabolic acidosis?

C) Educate the patient on the importance of adhering to prescribed sodium bicarbonate therapy between dialysis sessions.

A) Increase the frequency of hemodialysis sessions to improve acid-base balance.

B) Collaborate with the dietitian to enhance the patient's nutritional intake and overall health.

C) Educate the patient on the importance of adhering to prescribed sodium bicarbonate therapy between dialysis sessions.

D) Monitor the patient's blood pressure more frequently during dialysis to prevent further hypotensive episodes.

A patient with end-stage renal disease presents with hyperkalemia, hypocalcemia, and signs of fluid overload. The healthcare team has adjusted the patient's dialysis regimen and added calcium supplements. As the nurse, which intervention should be prioritized to prevent further complications?

A) Educate the patient on the importance of restricting dietary potassium.

B) Administer a potassium-sparing diuretic to manage peripheral edema.

C) Encourage increased fluid intake to dilute serum electrolyte concentrations.

D) Advise the patient to take calcium supplements on an empty stomach to enhance absorption.

A patient with end-stage renal disease presents with increased fatigue, muscle cramps, and occasional shortness of breath. The patient’s laboratory results show a serum potassium level of 5.8 mEq/L and a serum calcium level of 7.8 mg/dL. Which nursing intervention is most appropriate to include in the plan of care to address these findings?

B) Administer a calcium supplement as ordered and monitor for signs of hypocalcemia.

A) Encourage the patient to increase intake of potassium-rich foods like bananas and oranges.

B) Administer a calcium supplement as ordered and monitor for signs of hypocalcemia.

C) Restrict the patient's fluid intake to prevent further fluid overload.

D) Withhold the patient's phosphate binders to allow for higher calcium absorption.

End Stage Renal Disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic damage to nephron structures leads to a progressive decline in glomerular filtration rate (GFR). This loss of functional nephrons impairs the kidneys' ability to filter blood, resulting in toxic accumulation of waste products like urea and creatinine in the bloodstream.

• Secondary mechanism: Compensatory hyperfiltration in remaining nephrons initially maintains kidney function but eventually leads to glomerular sclerosis and further nephron loss. This cycle exacerbates renal decline and contributes to systemic hypertension, accelerating kidney damage.

• Key complication: Metabolic imbalances, such as hyperkalemia and acidosis, arise from impaired excretion of electrolytes and hydrogen ions. These imbalances can lead to life-threatening cardiac arrhythmias and necessitate careful monitoring and management in clinical practice.

Patient Profile

Demographics:

58-year-old male, retired factory worker

History:

• Key past medical history: Diabetes mellitus type 2, hypertension, chronic kidney disease stage 4

• Current medications: Metformin, Lisinopril, Furosemide, Erythropoietin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in legs

• Key symptoms: Shortness of breath, decreased urine output, nausea, itching

• Vital signs: Blood pressure 160/95 mmHg, heart rate 88 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the patient continues to experience worsening symptoms, a new set of lab results reveals several concerning developments. His serum potassium level has risen to 6.2 mEq/L, significantly above the normal range of 3.5-5.0 mEq/L, indicating hyperkalemia. This electrolyte imbalance poses a substantial risk for cardiac arrhythmias, which necessitates immediate intervention. In addition, his blood urea nitrogen (BUN) and creatinine levels have increased to 80 mg/dL and 7.5 mg/dL, respectively, reflecting further deterioration of renal function. Arterial blood gas analysis shows a pH of 7.28, bicarbonate level of 16 mEq/L, and partial pressure of carbon dioxide (PaCO2) at 32 mmHg, indicating a metabolic acidosis with partial respiratory compensation.

The patient's clinical status also shows signs of further decline. He reports experiencing more frequent and severe episodes of nausea, and his appetite has significantly decreased, leading to noticeable weight loss. His blood pressure remains elevated at 165/98 mmHg despite antihypertensive therapy, and there is increasing peripheral edema. Auscultation reveals bilateral crackles at the lung bases, suggesting possible fluid overload, and correlating with his complaint of shortness of breath. These findings indicate the need for urgent hemodialysis initiation to manage the metabolic derangements and fluid overload effectively.

Prompt recognition and management of these complications are crucial. The interdisciplinary team must evaluate the risks and benefits of starting dialysis while considering the patient's overall health status and quality of life. The healthcare team should also reassess his medication regimen, especially the dosages of Lisinopril and Furosemide, to optimize his blood pressure control and fluid status. Collaborative efforts are essential to stabilize the patient, prevent further complications, and prepare for potential long-term renal replacement therapy.

Section 2

As the healthcare team prepares for the initiation of hemodialysis, a new set of diagnostic results arrives, revealing further complexities in the patient's condition. The electrocardiogram (ECG) results display peaked T-waves and a widened QRS complex, both indicative of severe hyperkalemia and its potential impact on cardiac function. This finding underscores the urgency of addressing the elevated serum potassium level. Concurrently, a chest X-ray confirms pulmonary congestion, correlating with the bilateral crackles and suggesting worsening fluid overload. These diagnostic insights necessitate immediate action to prevent cardiac complications and respiratory distress.

In response to these developments, the team decides to administer calcium gluconate intravenously to stabilize the cardiac membrane and temporarily protect against arrhythmias. Additional measures include the administration of insulin and glucose to drive potassium back into the cells, alongside consideration of sodium polystyrene sulfonate for gastrointestinal elimination of potassium. Furthermore, the patient's antihypertensive regimen is reassessed with a potential adjustment in Lisinopril dosage, considering the risk of hyperkalemia. Furosemide may be temporarily increased to enhance diuresis and reduce fluid overload, but this must be carefully balanced with the patient's declining renal function.

These interventions aim to stabilize the patient's immediate clinical status and mitigate the risks posed by his metabolic and electrolyte imbalances. The healthcare team remains vigilant, closely monitoring his cardiac rhythm, respiratory status, and laboratory values. As they proceed with hemodialysis, the team will continue to evaluate the patient's response to treatment, anticipating potential challenges in managing his complex condition. This multidisciplinary approach aims to optimize his current health status while planning for long-term management strategies, including possible renal replacement therapy options.

Section 3

Response to Interventions:

Following the administration of calcium gluconate, the patient's cardiac rhythm showed signs of stabilization, with a reduction in the amplitude of the peaked T-waves on the ECG. This initial response provided some reassurance to the healthcare team, indicating a temporary protective effect against arrhythmias. Concurrently, the insulin and glucose therapy effectively reduced the serum potassium levels from 6.8 mEq/L to 5.5 mEq/L, as reflected in the latest laboratory results. However, the team remained cautious, understanding that this was a transient solution and that the underlying issue of renal clearance needed to be addressed promptly.

The patient's respiratory status, however, remained a significant concern. Despite the administration of furosemide, the chest X-ray continued to show evidence of pulmonary congestion. Physical examination revealed persistent bilateral crackles, and the patient reported increasing dyspnea, with a respiratory rate climbing to 24 breaths per minute. Oxygen saturation dropped to 90% on room air, necessitating supplemental oxygen to maintain adequate levels. This development indicated that the fluid overload was not adequately resolving, prompting the team to focus on optimizing the timing and settings of the upcoming hemodialysis session to more effectively address the fluid and electrolyte imbalances.

As the patient was prepared for hemodialysis, the multidisciplinary team discussed potential adjustments to his management plan. They considered increasing the frequency of dialysis sessions in the immediate term to better control his fluid status and electrolyte balance. Additionally, they planned to reevaluate his medication regimen, particularly the use of Lisinopril, given the ongoing risk of hyperkalemia and its contribution to his current condition. The team remained vigilant, ready to respond to any further changes in the patient's status, and committed to closely monitoring his progress through the initial phases of renal replacement therapy.

Section 4

As the hemodialysis session commenced, the patient initially tolerated the procedure well. However, midway through the treatment, the nurse observed a change in the patient's status. The patient began to exhibit signs of hypotension, with his blood pressure dropping to 88/56 mmHg. He reported feeling dizzy and lightheaded, prompting immediate intervention. The dialysis team quickly adjusted the ultrafiltration rate to decrease fluid removal and administered a small bolus of normal saline to stabilize his blood pressure. These actions were successful in preventing further decline, and the patient’s blood pressure gradually improved to a more stable 100/64 mmHg.

Simultaneously, new laboratory results were received, providing additional insights into the patient's condition. The patient's serum bicarbonate level was notably low at 16 mEq/L, indicating a persistent metabolic acidosis despite the ongoing dialysis. This finding suggested that the patient's acid-base balance was not being adequately managed and required further attention. The nephrologist reviewed these results and adjusted the dialysate composition to include a higher bicarbonate concentration in subsequent sessions. Additionally, the patient's serum albumin was found to be 2.9 g/dL, reflecting poor nutritional status, likely contributing to his compromised immune function and overall recovery.

The team recognized these developments as an opportunity to refine the patient's management plan further. They planned to initiate dietary consultations to address his nutritional deficits and discuss potential supplementation. Additionally, the healthcare team considered the introduction of sodium bicarbonate therapy to help correct the metabolic acidosis between dialysis sessions. These considerations highlighted the complexity of managing end-stage renal disease, requiring careful coordination and clinical reasoning to optimize the patient's outcomes. As the patient was monitored closely following dialysis, the team remained vigilant for any further complications that could arise in this critical phase of care.

Section 5

Following the initial interventions, the patient's condition appeared to stabilize temporarily. However, during a routine follow-up visit, the patient reported experiencing increased fatigue, muscle cramps, and occasional shortness of breath, raising concerns about potential new complications. A comprehensive assessment was performed, revealing that the patient's blood pressure was persistently low at 92/58 mmHg, and he had developed mild peripheral edema, particularly in the lower extremities. Auscultation of the lungs indicated slight crackles at the bases, suggesting fluid overload or early pulmonary congestion.

Subsequent laboratory tests highlighted a significant electrolyte imbalance. The patient's serum potassium level had risen to 5.8 mEq/L, indicating hyperkalemia, a potentially dangerous condition in the context of renal failure. Additionally, his serum calcium was measured at 7.8 mg/dL, suggesting hypocalcemia, which could further contribute to his muscle cramps and fatigue. These findings necessitated a reevaluation of the patient's medication regimen, particularly his phosphate binders and any potassium-sparing medications, to prevent exacerbation of these imbalances.

In response to these developments, the healthcare team adjusted the patient's dialysis prescription to more effectively manage fluid and electrolyte removal. They increased the duration and frequency of his dialysis sessions to help control the hyperkalemia and address the fluid overload. The nephrologist also added a calcium supplement to the patient's treatment plan to correct the hypocalcemia. As the team implemented these changes, they emphasized the importance of regular monitoring and patient education to prevent further complications, ensuring the patient's involvement in his care to enhance adherence to dietary and medication recommendations. This proactive approach aimed to stabilize the patient's condition and prevent further deterioration while addressing the multifaceted challenges of managing end-stage renal disease.